ORCHESTRA德尔菲共识:风湿性疾病患者SARS-CoV-2感染的诊断与治疗管理
该共识由14名国际专家组成专家组,经系统文献综述后采用德尔菲法,就风湿性疾病合并COVID-19患者的临床、诊断和治疗管理提出24个问题,经最多三轮投票(6点Likert量表,共识阈值≥80%),最终23/24个问题达成共识,形成10条推荐。共识认为在科学证据不足的领域可通过德尔菲法形成推荐,供风湿性疾病患者管理决策参考,同时等待更好的证据。
要点
- 14名国际专家经系统文献综述后采用德尔菲法,就24个问题投票。
- 共识阈值要求简单或累积同意≥80%,最多三轮。
- 最终23/24个问题达成共识,形成10条推荐。
核心结论
- 德尔菲法使证据不足领域的推荐达成共识,可供风湿性疾病患者管理决策参考,同时等待更好的证据。
研究设计与样本
- 由14名国际专家组成专家组,经系统文献综述后采用德尔菲法进行共识,提出24个问题并以6点Likert量表投票,共识要求简单或累积同意≥80%,最多三轮。
主要发现
- 三轮后24个问题中23个达成共识,形成10条推荐。
关键数值与推荐
- 投票采用6点Likert量表:1强烈不同意、2不同意、3有些不同意、4有些同意、5同意、6强烈同意。
- 共识要求简单或累积同意≥80%,最多三轮。
- 累积同意定义为第1-2项(强烈不同意+不同意)、第2-3项(不同意+有些不同意)、第4-5项(有些同意+同意)或第5-6项(同意+强烈同意)的应答百分比之和,区分强同意(同意+强烈同意)或强不同意(强烈不同意+不同意)与中等同意(有些同意+同意)或中等不同意(不同意+有些不同意)。
临床怎么用
- 原文未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The clinical management of COVID-19 in immunocompromised patients remains a challenge. This work aimed to develop a consensus to establish recommendations for the clinical, diagnostic, and therapeutic management of patients with rheumatic diseases and COVID-19. METHODS: A panel of 14 international experts was selected, and Delphi methodology was used for the consensus, after a systematic literature review. Twenty-four questions were formulated and presented to the panel. The experts voted using a 6-point Likert scale (1) 'Strongly disagree' (SD); (2) 'Disagree' (D); (3) 'Somewhat disagree' (SWD); (4) 'Somewhat agree' (SWA); (5) 'Agree' (A); (6) 'Strongly agree' (SA). To establish consensus, simple or cumulative agreement ≥80% was required over a maximum of three rounds. Cumulative agreement was defined as the sum of response percentages on items 1-2 (SD + D); 2-3 (D + SWD); 4-5 (SWA + A); or 5-6 (A + SA), distinguishing a strong degree of agreement (A + SA) or disagreement (SD + D) from a moderate degree of agreement (SWA + A) or disagreement (D + SWD). RESULTS: After the three rounds, consensus was reached on 23 of the 24 questions and 10 recommendations were made. DISCUSSION: The Delphi methodology allowed consensus on recommendations in areas with insufficient scientific evidence, which can be considered for decision-making in the management of patients with rheumatological diseases while awaiting better evidence.
引用
- Caponcello MG, Navarro PO, Bonazzetti C, et al. ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in patients with rheumatological diseases. Clin Microbiol Infect. 2025. PMID: 40049395. doi:10.1016/j.cmi.2025.02.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。